| A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects (NCT01818011) | GlaxoSmithKline | 2013-08-07 |
| Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion (NCT02275364) | GlaxoSmithKline | 2013-08-05 |
| ROTAHALER Device Optimization Study (NCT01890863) | GlaxoSmithKline | 2013-08-05 |
| N. Meningitidis Carriage Study (NCT01808365) | GlaxoSmithKline | 2013-08-02 |
| A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis (NCT01916226) | GlaxoSmithKline | 2013-08-01 |
| Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination (NCT01915888) | GlaxoSmithKline | 2013-08-01 |
| A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors (NCT01920568) | GlaxoSmithKline | 2013-08-01 |
| Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines (NCT01738841) | GlaxoSmithKline | 2013-08-01 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin (NCT01929863) | GlaxoSmithKline | 2013-08-01 |
| Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines (NCT01905215) | GlaxoSmithKline | 2013-07-22 |
| Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder (NCT01847430) | GlaxoSmithKline | 2013-07-19 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older (NCT01878825) | GlaxoSmithKline | 2013-07-18 |
| Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses (NCT01894386) | GlaxoSmithKline | 2013-07-15 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older (NCT01878812) | GlaxoSmithKline | 2013-07-11 |
| A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects. (NCT01899755) | GlaxoSmithKline | 2013-07-10 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older (NCT01884519) | GlaxoSmithKline | 2013-07-01 |
| Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants (NCT01890850) | GlaxoSmithKline | 2013-07-01 |
| A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above (NCT01873365) | GlaxoSmithKline | 2013-06-29 |
| Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects (NCT01873339) | GlaxoSmithKline | 2013-06-19 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection (NCT01746108) | GlaxoSmithKline | 2013-06-18 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 (NCT01831804) | GlaxoSmithKline | 2013-06-17 |
| Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years (NCT01777321) | GlaxoSmithKline | 2013-06-17 |
| A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects (NCT01879462) | GlaxoSmithKline | 2013-06-14 |
| A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01879410) | GlaxoSmithKline | 2013-06-13 |
| A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor (NCT01853878) | GlaxoSmithKline | 2013-06-12 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ) (NCT01867996) | GlaxoSmithKline | 2013-06-11 |
| Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster (NCT01827839) | GlaxoSmithKline | 2013-06-10 |
| A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition (NCT02498288) | GlaxoSmithKline | 2013-05-31 |
| A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride (NCT04123665) | GlaxoSmithKline | 2013-05-28 |
| Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects (NCT01827657) | GlaxoSmithKline | 2013-05-28 |
| A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects (NCT01842607) | GlaxoSmithKline | 2013-05-27 |
| Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects (NCT01827631) | GlaxoSmithKline | 2013-05-27 |
| Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions (NCT01797926) | GlaxoSmithKline | 2013-05-23 |
| Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study. (NCT01899638) | GlaxoSmithKline | 2013-05-20 |
| Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults (NCT01857869) | GlaxoSmithKline | 2013-05-20 |
| Proof of Concept (POC) in Patients With Ischaemic Stroke (NCT01808261) | GlaxoSmithKline | 2013-05-18 |
| Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions (NCT01847417) | GlaxoSmithKline | 2013-05-16 |
| Feasibility Study of Exenatide by Continuous Subcutaneous Infusion (NCT01857895) | GlaxoSmithKline | 2013-05-16 |
| Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions (NCT01847404) | GlaxoSmithKline | 2013-05-14 |
| Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848). (NCT01852565) | GlaxoSmithKline | 2013-05-14 |
| A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis (NCT01777243) | GlaxoSmithKline | 2013-05-13 |
| Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination (NCT01777308) | GlaxoSmithKline | 2013-05-03 |
| An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes (NCT01817777) | GlaxoSmithKline | 2013-05-01 |
| DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD) (NCT01868009) | GlaxoSmithKline | 2013-05-01 |
| Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations (NCT01847443) | GlaxoSmithKline | 2013-05-01 |
| Minocycline Bioequivalence Study (NCT01938508) | GlaxoSmithKline | 2013-05-01 |
| The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects (NCT01879423) | GlaxoSmithKline | 2013-04-28 |
| Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers (NCT01827644) | GlaxoSmithKline | 2013-04-24 |
| A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia (NCT01831791) | GlaxoSmithKline | 2013-04-14 |
| A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures (NCT01777139) | GlaxoSmithKline | 2013-04-11 |
| A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01822899) | GlaxoSmithKline | 2013-04-04 |
| A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study (NCT01822639) | GlaxoSmithKline | 2013-04-03 |
| A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris (NCT01915732) | GlaxoSmithKline | 2013-04-01 |
| The Evaluation of Belimumab in Myasthenia Gravis (MG) (NCT01480596) | GlaxoSmithKline | 2013-04-01 |
| Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka (NCT01803425) | GlaxoSmithKline | 2013-04-01 |
| Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache (NCT01842633) | GlaxoSmithKline | 2013-04-01 |
| Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka (NCT01551537) | GlaxoSmithKline | 2013-04-01 |
| A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia (NCT01808326) | GlaxoSmithKline | 2013-04-01 |
| Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians (NCT01920464) | GlaxoSmithKline | 2013-04-01 |
| Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy (NCT01762852) | GlaxoSmithKline | 2013-04-01 |
| An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures (NCT01607346) | GlaxoSmithKline | 2013-03-27 |
| Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure (NCT01788228) | GlaxoSmithKline | 2013-03-22 |
| AUGMENTIN™ in Dental Infections (NCT02141217) | GlaxoSmithKline | 2013-03-21 |
| Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea (NCT01766206) | GlaxoSmithKline | 2013-03-15 |
| OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck. (NCT01842620) | GlaxoSmithKline | 2013-03-13 |
| A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS) (NCT01808482) | GlaxoSmithKline | 2013-03-13 |
| Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older (NCT01751165) | GlaxoSmithKline | 2013-03-12 |
| A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT01725139) | GlaxoSmithKline | 2013-03-08 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy (NCT01798056) | GlaxoSmithKline | 2013-03-06 |
| To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies (NCT01788813) | GlaxoSmithKline | 2013-03-01 |
| To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma (NCT01808339) | GlaxoSmithKline | 2013-03-01 |
| An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184 (NCT01777256) | GlaxoSmithKline | 2013-03-01 |
| Post Marketing Surveillance for Contac Bien Z in Japan (NCT02020902) | GlaxoSmithKline | 2013-03-01 |
| A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01817764) | GlaxoSmithKline | 2013-03-01 |
| A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. (NCT01440361) | GlaxoSmithKline | 2013-03-01 |
| Milk-only Lactation Study for Patients on Eltrombopag (NCT01055600) | GlaxoSmithKline | 2013-03-01 |
| A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis (NCT01782664) | GlaxoSmithKline | 2013-03-01 |
| Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama (NCT01793857) | GlaxoSmithKline | 2013-03-01 |
| Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers (NCT01767467) | GlaxoSmithKline | 2013-03-01 |
| Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy (NCT01772160) | GlaxoSmithKline | 2013-02-26 |
| Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System (NCT01777295) | GlaxoSmithKline | 2013-02-25 |
| Rosuvastatin Calcium Bioequivalence Study - Fast (NCT01711749) | GlaxoSmithKline | 2013-02-25 |
| A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus (NCT01777282) | GlaxoSmithKline | 2013-02-23 |
| Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) (NCT01910662) | GlaxoSmithKline | 2013-02-22 |
| A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers (NCT01818024) | GlaxoSmithKline | 2013-02-22 |
| Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry (NCT01729455) | GlaxoSmithKline | 2013-02-21 |
| Prospective Sexual Function Study for BPH Subjects (NCT01777269) | GlaxoSmithKline | 2013-02-18 |
| Single Dose Escalation Study of GSK2838232 in Healthy Subjects (NCT01802918) | GlaxoSmithKline | 2013-02-18 |
| Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma (NCT01767454) | GlaxoSmithKline | 2013-02-12 |
| To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes (NCT01725126) | GlaxoSmithKline | 2013-02-10 |
| Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk (NCT02254460) | GlaxoSmithKline | 2013-02-06 |
| A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies (NCT01725100) | GlaxoSmithKline | 2013-02-05 |
| Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI) (NCT01716533) | GlaxoSmithKline | 2013-02-02 |
| Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity (NCT01827670) | GlaxoSmithKline | 2013-02-01 |
| A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects (NCT01751113) | GlaxoSmithKline | 2013-02-01 |
| A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis (NCT01658605) | GlaxoSmithKline | 2013-02-01 |
| Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg (NCT01762800) | GlaxoSmithKline | 2013-02-01 |
| A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT01733758) | GlaxoSmithKline | 2013-02-01 |
| REMS Retigabine Study (NCT01938560) | GlaxoSmithKline | 2013-02-01 |
| Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis (NCT01772199) | GlaxoSmithKline | 2013-02-01 |